Epithelial recognition and elimination against aberrant cells.
- Published in:
- Seminars in Immunopathology, 2024, v. 45, n. 4-6, p. 521, doi. 10.1007/s00281-024-01001-0
- By:
- Publication type:
- Article
Works matching IS 18632297 AND DT 2024 AND VI 45 AND IP 4-6
Results: 9
1
2
Disease pathogenesis and barrier functions regulated by group 3 innate lymphoid cells.
- Published in:
- Seminars in Immunopathology, 2024, v. 45, n. 4-6, p. 509, doi. 10.1007/s00281-024-01000-1
- By:
- Publication type:
- Article
3
Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity.
- Published in:
- Seminars in Immunopathology, 2024, v. 45, n. 4-6, p. 493, doi. 10.1007/s00281-023-00999-z
- By:
- Publication type:
- Article
4
Physiological and immunological barriers in the lung.
- Published in:
- Seminars in Immunopathology, 2024, v. 45, n. 4-6, p. 533, doi. 10.1007/s00281-024-01003-y
- By:
- Publication type:
- Article
5
Correction: Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
6
Publisher Correction: Epithelial recognition and elimination against aberrant cells.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
7
Causes and costs of global COVID-19 vaccine inequity.
- Published in:
- Seminars in Immunopathology, 2024, v. 45, n. 4-6, p. 469, doi. 10.1007/s00281-023-00998-0
- By:
- Publication type:
- Article
8
The overlooked bacterial pandemic.
- Published in:
- Seminars in Immunopathology, 2024, v. 45, n. 4-6, p. 481, doi. 10.1007/s00281-023-00997-1
- By:
- Publication type:
- Article
9
The role of vaccines in the COVID-19 pandemic: what have we learned?
- Published in:
- Seminars in Immunopathology, 2024, v. 45, n. 4-6, p. 451, doi. 10.1007/s00281-023-00996-2
- By:
- Publication type:
- Article